Skip to main content

Day: January 6, 2021

RENNOVA COMPLETES AGREEMENT TO SEPARATE ITS OFTWARE AND GENETIC DIAGNOSTICS INTERPRETATION DIVISIONS INTO INNOVAQOR, INC. (OTC: INOQ)

WEST PALM BEACH, Fla., Jan. 06, 2021 (GLOBE NEWSWIRE) — Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW) (“Rennova” or the “Company”), an owner and operator of rural hospitals in Tennessee, announces that on December 31. 2020, it completed an agreement with InnovaQor, Inc. (OTC: INOQ) (InnovaQor) a CO based public company, to merge its software and genetic testing interpretation divisions, Health Technology Solutions, Inc. (HTS) and Advanced Molecular Services Group, Inc., (AMSG) and their subsidiaries into InnovaQor. After closing these entities will operate as wholly owned subsidiaries of InnovaQor. Closing is subject to a number of customary conditions for a transaction of this nature and is intended to happen on or before January 31. 2020.InnovaQor has previously completed a license agreement giving it certain rights to assets...

Continue reading

Blockchain Foundry Announces Private Placement Financing and Provides Corporate Update

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR RELEASE, PUBLICATION OR DISSEMINATION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.TORONTO, Jan. 06, 2021 (GLOBE NEWSWIRE) — Blockchain Foundry Inc. (“BCF” or the “Company”) (CSE:BCFN), a leading North American blockchain development firm, is pleased to announce that it has closed a non-brokered private placement (the “Private Placement”) of units (the “Units”) with a group of strategic investors. The Company issued 3,555,556 Units at a price of $0.225 per Unit for gross proceeds of $800,000. Each Unit is comprised of one common share (each a “Common Share”) and one Common Share purchase warrant (a “Warrant”). Each Warrant entitles the holder thereof to purchase one Common Share (each, a “Warrant...

Continue reading

Cayuse Growth Continues with Acquisition of London-Based Haplo

Portland, OR, Jan. 06, 2021 (GLOBE NEWSWIRE) — Cayuse, provider of the market-leading research administration cloud platform, announced today the acquisition of Haplo, one of the leading research information management solutions in the UK and a growing customer base in Australia and New Zealand. This acquisition comes on the heels of another year of growth that included the launch of the industry’s first purpose-built and cloud-native research platform. Supported by the recent investment by Primus Capital, Cayuse continues to pursue its mission to help research organizations worldwide advance their impact on science, discovery and society.“We’re excited about the potential this combination of Haplo’s innovative researcher solutions and our end-to-end research suite brings to delivering long term value to the entire global research...

Continue reading

Cerner to Present at 39th Annual J.P. Morgan Healthcare Conference

KANSAS CITY, Mo., Jan. 06, 2021 (GLOBE NEWSWIRE) — Cerner Corporation (Nasdaq: CERN) announced today that Chairman and CEO Brent Shafer, President Don Trigg and Executive Vice President and Chief Financial Officer Marc Naughton will present at the 39th Annual J.P. Morgan Healthcare Conference. The presentation will begin at 10:00 a.m. EST on Jan. 13, and will be available live and archived on Cerner’s website in the Investor Relations section.   The presentation may include discussion of Cerner developments and other material and forward-looking information about business and financial matters.About CernerCerner’s health technologies connect people and information systems at more than 27,500 contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. Recognized globally...

Continue reading

American BriVision Issues Shareholder Letter Outlining Achievements of 2020 and Outlook for 2021

FREMONT, CA, Jan. 06, 2021 (GLOBE NEWSWIRE) —via NewMediaWire — American BriVision (Holding) Corporation (OTCQB: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, central nervous system (CNS), and ophthalmology, yesterday issued a letter to its more than 700 shareholders describing the company’s achievements in 2020 and goals for 2021. The letter from Dr. Howard Doong, CEO of ABVC, is reprinted below in its entirety.Dear Shareholder:Now that 2020 has ended, we believe it will be informative to you, our shareholders, to hear about our goals for 2021. But first, we note that 2020 was an exceptional year for the company, particularly with respect to our medical device, Vitargus®, and our medicine ABV-1505, which is designed to alleviate attention-deficit hyperactivity disorder...

Continue reading

MusclePharm to Participate in Fireside Chat at the 23rd Annual ICR Conference

CALABASAS, Calif., Jan. 06, 2021 (GLOBE NEWSWIRE) — MusclePharm Corporation (OTCMKTS: MSLP) (the “Company”), a global provider of leading sports nutrition & lifestyle branded nutritional supplements, today announced that Ryan Drexler, the Company’s President and Chief Executive Officer, will host a fireside chat at the 23rd Annual ICR Conference.The conference will be held January 11-14, 2021 in a virtual format. The Company’s fireside chat will be held on Wednesday, January 13, 2021 at 9:30 am Eastern time. The Company will also be participating in virtual one-on-one and small group meetings.About MusclePharm, Inc.MusclePharm® is an award-winning, worldwide leading sports nutrition & lifestyle company offering branded nutritional supplements. Its portfolio of recognized properties include the MusclePharm® Sport Series,...

Continue reading

Globus Maritime Announces New Charter for the M/V Moon Globe

GLYFADA, Greece, Jan. 06, 2021 (GLOBE NEWSWIRE) — Globus Maritime Limited (the “Company” or “Globus”) (NASDAQ: GLBS), a dry bulk shipping company, announced today that it has secured new time charter employment for its vessel Moon Globe (a 74,432-deadweight ton built Panamax dry bulk carrier built in 2005, at Hudong-Zhonghua Shipyard in China).The vessel has been chartered to an unrelated charterer. The charter commences on January 21, 2021 and has a minimum duration of three months and a maximum duration of six months, at the charterer’s option (plus 15 days for redelivery), which is expected to generate gross revenue of approximately $1.3 million assuming the charter continues for the minimum scheduled period and approximately $2.4 million if the charter continues for the maximum period, in each case assuming no offhire...

Continue reading

Trupanion Announces Participation at the 23rd Annual Needham Virtual Growth Conference

SEATTLE, Jan. 06, 2021 (GLOBE NEWSWIRE) — Trupanion, Inc. (Nasdaq: TRUP) announced today that the Company will participate in the 23rd Annual Needham Virtual Growth Conference on Wednesday, January 13, 2021. Darryl Rawlings, Trupanion’s founder and Chief Executive Officer, is scheduled to present virtually at 10:00 am ET and will participate in virtual meetings with investors throughout the day.The presentation will be webcast live and can be accessed on Trupanion’s Investor Relations website at http://investors.trupanion.com.About TrupanionTrupanion is a leader in medical insurance for cats and dogs throughout the United States and Canada. For over two decades, Trupanion has given pet owners peace of mind so they can focus on their pet’s recovery, not financial stress. Trupanion is committed to providing pet owners with the...

Continue reading

Innovative Payment Solutions, Inc. Adds Richard Rosenblum to Advisory Board

NORTHRIDGE, Calif., Jan. 06, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Innovative Payment Solutions, Inc. (“Innovative” or the “Company”) (OTCQB: IPSI), a U.S.-based fintech company focused on building a 21st century digital payment solution, IPSIPay, is pleased to announce the addition of Richard Rosenblum to an Advisory Board.Richard is a business veteran and entrepreneur in the areas of the financial services, capital markets, healthcare and technology. Richard’s experience ranges from managing director at several investment merchant banks as well as C-suite executive. Previously, from 2008-2014 Mr. Rosenblum was a Director, President and Executive Chairman of Alliqua Biomedical, Inc., a leader in hydrogel manufacturing technology in the wound care sector.As a founder of Harborview Capital, he leads a team of strategic...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.